Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maxigen Biotech Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Cash & Cash Equivalents
NT$520.8m
CAGR 3-Years
36%
CAGR 5-Years
20%
CAGR 10-Years
24%
G
Grape King Bio Ltd
TWSE:1707
Cash & Cash Equivalents
NT$4B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
20%
Maywufa Co Ltd
TWSE:1731
Cash & Cash Equivalents
NT$190.3m
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Chlitina Holding Ltd
TWSE:4137
Cash & Cash Equivalents
NT$5.5B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
7%

See Also

What is Maxigen Biotech Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
520.8m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Cash & Cash Equivalents amounts to 520.8m TWD.

What is Maxigen Biotech Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
24%

Over the last year, the Cash & Cash Equivalents growth was 29%. The average annual Cash & Cash Equivalents growth rates for Maxigen Biotech Inc have been 36% over the past three years , 20% over the past five years , and 24% over the past ten years .

Back to Top